The genetic factors in AD include pathogenic genes and risk genes, which can promote or inhibit the development of AD by affecting the metabolism of Aβ or tau proteins, or influencing pathways such as immune responses, inflammatory responses, and oxidative stress (Scheltens et al., 2021; Jansen et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.